Tag Archives: Joseph Pantginis

H.C. Wainwright Keeps a Buy Rating on IMV Inc. (IMV)

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on IMV Inc. (IMV – Research Report), with a price target of $11.50. The company’s shares closed yesterday at $4. Pantginis wrote: “Valuation and risks to

H.C. Wainwright Keeps Their Buy Rating on Oxford BioMedica plc (OXBDF)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Oxford BioMedica plc (OXBDF – Research Report) today and set a price target of $14.50. The company’s shares opened today at $9.70, close to its 52-week low of $7.97. Pantginis

IMV Inc. (IMV) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on IMV Inc. (IMV – Research Report) today and set a price target of $11.50. The company’s shares closed on Friday at $4.33. Pantginis commented: “Valuation and risks to price target

Genocea Biosciences (GNCA) Gets a Buy Rating from H.C. Wainwright

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Genocea Biosciences (GNCA – Research Report), with a price target of $42. The company’s shares closed on Friday at $5.61. Pantginis observed: “Valuation and risks

H.C. Wainwright Reiterates a Buy Rating on Fibrocell Science Inc (FCSC)

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Fibrocell Science Inc (FCSC – Research Report), with a price target of $22. The company’s shares opened today at $2.20. Pantginis commented: “Valuation and risks

Oxford BioMedica plc (OXBDF) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Oxford BioMedica plc (OXBDF – Research Report) today and set a price target of $14.50. The company’s shares opened today at $10.02. Pantginis commented: “Valuation and risks to price target